Analysis of Innovation and Development of China's IVD Industry in the Age of Big Data

Sujuan Zhang; Yanfeng Wang

doi:10.54691/bcpbm.v27i.1981

Authors

Sujuan Zhang
Yanfeng Wang

DOI:

https://doi.org/10.54691/bcpbm.v27i.1981

Keywords:

big data, in vitro diagnosis, signal and measurement

Abstract

At present, about two-thirds of global medical decision-making was based on diagnosis, and in vitro diagnosis (IVD) was an important part of the process of preventing diagnosis and treatment of diseases. According to a report by Markets in December 2016, the total global IVD market in 2016 reached US$60.22 billion. It was expected to grow rapidly at a compound annual growth rate of 5.5% from 2016 to 2021. By 2021, it will reach US$78.74 billion, of which China is the fastest growing market in the world. This paper summarized the problems encountered in the IVD core technology system and the development status of IVD industry in China, and proposes feasible countermeasures for the innovation development of IVD industry in China.

Downloads

Download data is not yet available.

References

Li Yaohua, Zhang Shiqing. Review and prospect of IVD reagent industry development[J]. Laboratory Medicine and Clinical Medicine, 2017, 14(2): 299-301.

Zhang Chao. The development of IVD industry is promising [J]. Capital Foods and Medicine, 2017, 24 (7): 12-13.

Zhang Jinsong, Li Lin. Application of POCT in emergency medicine [C]. The 9th Organizing Conference of Chinese Journal of Emergency Medicine and the 2nd Emergency Medical Youth Forum National Emergency and Rescue Medicine Class. 2010.

Xu Jianxin, Li Fugang. New opportunities brought by POCT to traditional medical models [J]. Chinese Journal of Laboratory Medicine, 2007, (12).

Zhou Yubao, Liu Fang. Current status and quality management of POCT detection[J]. International Journal of Laboratory Medicine, 2014, (21).